ABLS: Difference between revisions

From IxWiki
Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 18: Line 18:


Due to its size and political importance, ABLS began to emerge as a major influence in the civil biopharmaceutical sector during the late-20th century, as it had control of domestic production of vaccines, antibiotics and other essential medicines. When ABLS was dissolved in 1979, it was divested of control of all R&D institutes and manufacturing facilities, and its operations were privatized, forming several pharmaceutical companies which exist today.
Due to its size and political importance, ABLS began to emerge as a major influence in the civil biopharmaceutical sector during the late-20th century, as it had control of domestic production of vaccines, antibiotics and other essential medicines. When ABLS was dissolved in 1979, it was divested of control of all R&D institutes and manufacturing facilities, and its operations were privatized, forming several pharmaceutical companies which exist today.
== History ==
== Operations ==
=== Facilities ===
=== Programs and projects ===
[[Category:Caphiria]]
[[Category:Caphiria]]
[[Category:Biological warfare]]
[[Category:Biological warfare]]
[[Category:Medical research institutes in Caphiria]]
[[Category:Medical research institutes in Caphiria]]

Revision as of 20:51, 11 March 2022

Office of Applied Biochemistry and Life Sciences
Office overview
Formed1 February 1964
Dissolved12th July 1979
TypeResearch and development agency
JurisdictionGovernment of Caphiria
Employees40,000 (1976)
Office executive
  • Karlanoi Picarpintoni, Director
Parent departmentDepartment of Civilian Defense
Parent OfficeOffice of Advanced Research and Development

The Office of Applied Biochemistry and Life Sciences (ABLS) was the research and development agency responsible for the development of Caphiria's offensive biological warfare program during the Occidental Cold War. ABLS was organized under the Office of Advanced Research and Development (ORAD), which makes up part of the Department of Civilian Defense.

At its peak of operation, ABLS consisted of five major military-focused research institutes, numerous design and instrument-making facilities, three pilot plants and five dual-use production plants, and employed 40,000 personnel. ABLS pursued major offensive R&D programs which genetically engineered microbial strains to be resistant to an array of antibiotics. In addition, bacterial agents were created with the ability to produce various peptides, yielding strains with wholly new and unexpected pathogenic properties.

Due to its size and political importance, ABLS began to emerge as a major influence in the civil biopharmaceutical sector during the late-20th century, as it had control of domestic production of vaccines, antibiotics and other essential medicines. When ABLS was dissolved in 1979, it was divested of control of all R&D institutes and manufacturing facilities, and its operations were privatized, forming several pharmaceutical companies which exist today.

History

Operations

Facilities

Programs and projects